Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/3/16 → 12/31/25 |
Funding
- Intercept Pharmaceuticals Incorporated: $622,943.63
A Phase 3, Double-Blind, Randomised, Long Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholoic Acid in Subjects with Nonalcoholoic Steatohepatitis
- Chaudhuri, Ajay (PI)
- Talal, Andrew (PI)
Project: Research